EU-wide OTC orlistat licence sought by GSK

摘要

Reclassification of orlistat as a non-prescription medicine throughout the EU is being sought by GlaxoSmithKline.The company is the first to seek to use the European Medicines Agency's centralised procedure to license an OTC medicine.